APOA1 and neoplasm: Recent studies indicated that ApoA-1 could inhibit the formation of tumor vessels [12], induce an anti-tumor immune microenvironment that prevents tumor progression [13] and serve as a potential therapeutic target for patients with cancer [14–16].